Ambulatory and short-burst oxygen for interstitial lung disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 7, 2016, Pages

  Sharp, Charles ^a   Adamali, Huzaifa ^b   Millar, Ann B ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

AMBULATORY OXYGEN THERAPY; ASSESSMENT OF HUMANS; CHECKLIST; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; DATA ANALYSIS; DATA COLLECTION METHOD; DATA EXTRACTION; DATA SYNTHESIS; DISEASE EXACERBATION; DISEASE REGISTRY; DYSPNEA; EMBASE; ENDURANCE; EXERCISE; FIBROSING ALVEOLITIS; GRADING OF RECOMMENDATIONS ASSESSMENT, DEVELOPMENT AND EVALUATION CRITERIA; HOSPITALIZATION; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; OXYGEN DESATURATION; OXYGEN THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY BURST; REVIEW; RISK ASSESSMENT; SHORT BURST OXYGEN THERAPY; SURVIVAL RATE; SYSTEMATIC REVIEW; AMBULATORY CARE; EXERCISE TOLERANCE; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; PROCEDURES;

AMBULATORY CARE; DYSPNEA; EXERCISE TOLERANCE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84977628456     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011716.pub2     Document Type: Review

References (29)

1. Arizono S, Taniguchi H, Sakamoto K, Kondoh Y, Kimura T, Kataoka K, et al. Benefits of supplemental oxygen on exercise capacity in IPF patients with exercise-induced hypoxemia. European Respiratory Journal. 2015; Vol. 46, issue S59:OA4971.
2. Nishiyama O, Miyajima H, Fukai Y, Yamazaki R, Satoh R, Yamagata T, et al. Effect of ambulatory oxygen on exertional dyspnoea in IPF patients without resting hypoxemia. Respiratory Medicine 2013;107(8):1241-6.
3. Troy L, Young I, Munoz P, Taylor N, Webster S, Lau E, et al. Does supplemental oxygen increase exercise endurance in patients with idiopathic pulmonary fibrosis?. Respirology. 2014; Vol. 19:95.
4. Bye PT, Anderson SD, Woolcock AJ, Young IH, Alison JA. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. American Review of Respiratory Disease 1982;126(6):1005-12.
5. Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit?. European Respiratory Journal 2012;40(1):269-70.
6. Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. American Journal of Respiratory and Critical Care Medicine 1994;150(6):1616-22.
7. Leach RM, Davidson AC, Chinn S, Twort CH, Cameron IR, Bateman NT. Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax 1992;47(10):781-9.
8. Pouwels-Fry S, Pouwels S, Fournier C, Duchemin A, Tillie-Leblond I, Le Tourneau T, et al. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 2008;25(2):133-9.
9. Schaeffer MR, Ryerson CJ, Wilkie SS, Ramsook AH, Molgat-Seon Y, Khalil N, et al. Acute effects of supplemental oxygen on dyspnea, exercise endurance and respiratory neural drive in patients with fibrotic interstitial lung disease. American Journal of Respiratory and Critical Care Medicine. 2015; Vol. 191, issue Meeting Abstracts:A4400.
10. Tryfon MS, Mavrofridas E, Ilonidis G, Patakas D, Tryfon SM, Mavrofridis E. Cardiopulmonary effects of exercise, before and after oxygen delivery, in patients with usual interstitial pneumonia [Abstract]. European Respiratory Journal. 2003; Vol. 22:P639.
11. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, et al. Ambulatory oxygen in interstitial lung disease. European Respiratory Journal 2011;38(4):987-90.
12. Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx) (AmbOx). //clinicaltrials.gov/ct2/show/NCT02286063 accessed 29 June 2016.
13. British Thoracic Society (BTS) Working Group on Home Oxygen Services. Clinical component for the home oxygen service in England and Wales. www.brit-thoracic.org.uk/document-library/clinical-information/oxygen/home-oxygen-guideline-%28adults%29/bts-home-oxygen-in-adults-clinical-component/ (accessed 20 January 2015).
14. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61(11):980-5.
15. Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society Home Oxygen Guideline Development Group, on behalf of the British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015;70 Suppl 1:i1-i43.
16. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
17. Johnson-Warrington V, Williams J, Bankart J, Steiner M, Morgan M, Singh S. Pulmonary rehabilitation and interstitial lung disease: aiding the referral decision. Journal of Cardiopulmonary Rehabilitation and Prevention 2013;33(3):189-95.
18. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. The New England Journal of Medicine 2014;370(22):2083-92.
19. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. American Journal of Respiratory and Critical Care Medicine 2003;168(9):1084-90.
20. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxaemia. American Journal of Respiratory and Critical Care Medicine 1995;152(5 Pt 1):1616-9.
21. Nandi K, Smith AA, Crawford A, MacRae KD, Garrod R, See WA, et al. Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2003;58(8):670-3.
22. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011;66(6):462-7.
23. National Institute for Health and Care Excellence. Idiopathic pulmonary fibrosis: the diagnosis and management of suspected idiopathic pulmonary fibrosis. NICE guidelines [CG163]. Published June 2013. www.nice.org.uk/guidance/cg163 (accessed 20 January 2015).
24. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
25. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. The New England Journal of Medicine 2014;370(22):2071-82.
26. Roberts CM. Short burst oxygen therapy for relief of breathlessness in COPD. Thorax 2004;59(8):638-40.
27. Ryerson CJ, Donesky D, Pantilat SZ, Collard HR. Dyspnea in idiopathic pulmonary fibrosis: a systematic review. Journal of Pain and Symptom Management 2012;43(4):771-82.
28. Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2004;59(8):668-72.
29. Sharp C, Adamali H, Millar AB. Ambulatory and short-burst oxygen for interstitial lung disease. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD011716]